- December 3, 2021Epidemiologist explains why Omicron less likely to be lethal in India
CNBC TV-18 — December 3, 2021. Ramanan Laxminarayan explains that thanks to relatively high vaccination rates and widespread exposure to COVID-19 across India, the new Omicron variant will likely not have as devastating of an impact as the Delta wave.
Read moreRead more Read More
- December 2, 2021Covid: Omicron variant may be less lethal in India, says top epidemiologist
LiveMint — December 2, 2021. Given the widespread exposure of Indians to Covid-19 virus and a reasonably-high vaccination rate, India will likely be less affected by the new strain, Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy said in an interview with Bloomberg Television on Thursday. That may change if omicron […]
Read moreRead more Read More - December 1, 2021India extends door-to-door vaccine campaign as omicron variant worries officials
PBS NewsHour — December 1, 2021. “During the second wave, at least in urban India, upwards of 90 percent of people had already been exposed to the virus. And close to 40 percent of India’s already fully vaccinated. That’s probably giving sense to some sense of complacency amongst the public.” Ramanan Laxminarayan, Princeton economist and […]
Read moreRead more Read More - December 1, 2021CDDEP’s Founder Ramanan Laxminarayan on Omicron Risk in India
Bloomberg Markets Asia — December 1, 2021. In an interview with Bloomberg, Ramanan Laxminarayan of the Center for Disease Dynamics, Economics and Policy discusses the impact that the Omicron variant may have on India.
Read moreRead more Read More - November 19, 2021Building Evidence to Stop Superbugs with Jyoti Joshi
Superheroes Against Superbugs — November 19, 2021. “Lack of access to essential medicines (including antibiotics) contributes to inappropriate antibiotic use – excess or over-the-counter use- leading to AMR.” Jyoti Joshi, Head of South Asia, Center for Disease Dynamics, Economics and Policy (CDDEP).
Read moreRead more Read More - November 17, 2021How to help India amid the COVID crisis
The New York Times – OxygenForIndia delivers medical oxygen for free to patients in seven Indian cities. The group was founded by Ramanan Laxminarayan, an economist and epidemiologist who directs the Center for Disease Dynamics, Economics & Policy, a research outfit based in Washington and New Delhi.
Read moreRead more Read More - November 9, 2021Is India ‘beating’ Covid – or facing a deadly third wave?
The Week — November 9, 2021. “I expect a lot of the 103 million people that missed appointments were driven by fear to get their first dose because a lot of Indians were dying at the time, it was during the second wave. We aren’t seeing people rushing to get the vaccine like they did […]
Read moreRead more Read More - November 5, 2021Third Covid-19 wave fears for India as vaccination drive stalls
The Telegraph — November 5, 2021. “Vaccinations are driven by many things. I expect a lot of the 103 million people that missed appointments were driven by fear to get their first dose because a lot of Indians were dying at the time, it was during the second wave.” Ramanan Laxminarayan, director of the Center […]
Read moreRead more Read More - October 23, 2021Drug-resistant superbug thriving in hospitals hit hard by COVID-19
National Geographic — October 23, 2021. “Researchers are concerned about the role climate change will play in the spread of fungal infections,” Ramanan Laxminarayan, founder and director of the Center for Disease Dynamics, Economics & Policy in Washington, D.C.
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.
